CompletedPhase 1NCT03041363

Treatment Development of Triheptanoin (G1D)

Studying Epilepsy syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Juan Pascual
Principal Investigator
Juan Pascual
University of Texas Southwestern Medical Center
Intervention
Triheptanoin(drug)
Enrollment
12 enrolled
Eligibility
2-35 years · All sexes
Timeline
20172017

Study locations (1)

Collaborators

National Institute of Neurological Disorders and Stroke (NINDS)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03041363 on ClinicalTrials.gov

Other trials for Epilepsy syndrome

Additional recruiting or active studies for the same condition.

See all trials for Epilepsy syndrome

← Back to all trials